全部所有文章
-
聯生藥治療單純皰疹病毒抗體新藥UB-621獲美國FDA核准 執行臨床2期復發型生殖器皰疹試驗
聯生藥治療單純皰疹病毒抗體新藥UB-621獲美國FDA核准 執行臨床2期復發型生殖器皰疹試驗聯生藥治療單純皰疹病毒抗體新藥UB-621獲美國FDA核准 執行臨床2期復發型生殖器皰疹試驗more -
United Biopharma obtains approval from the U.S. FDA to conduct a clinical trial with UB-421 in Patients with Multi-Drug Resistance HIV-1 infection
United Biopharma obtains approval from the U.S. FDA to conduct a clinical trial with UB-421 in Patients with Multi-Drug Resistance HIV-1 infectionUnited Biopharma obtains approval from the U.S. FDA to conduct a clinical trial with UB-421 in Patients with Multi-Drug Resistance HIV-1 infectionmore -
聯生藥治療愛滋病抗體新藥UB-421獲美國FDA 核准執行 多重抗藥性臨床試驗
聯生藥治療愛滋病抗體新藥UB-421獲美國FDA 核准執行 多重抗藥性臨床試驗聯生藥治療愛滋病抗體新藥UB-421獲美國FDA 核准執行 多重抗藥性臨床試驗more -
United BioPharma Receives China NMPA Approval for UB-421 Phase 3 ART-Substitution Trial in HIV-infected Patients
United BioPharma Receives China NMPA Approval for UB-421 Phase 3 ART-Substitution Trial in HIV-infected PatientsUnited BioPharma Receives China NMPA Approval for UB-421 Phase 3 ART-Substitution Trial in HIV-infected Patientsmore -
聯生藥治療愛滋病抗體新藥UB-421獲中國國家藥品監督管理局 核准多國多中心臨床3期試驗
聯生藥治療愛滋病抗體新藥UB-421獲中國國家藥品監督管理局 核准多國多中心臨床3期試驗聯生藥治療愛滋病抗體新藥UB-421獲中國國家藥品監督管理局 核准多國多中心臨床3期試驗more -
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption(N Engl J Med 2019; 380:1535-1545)
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption(N Engl J Med 2019; 380:1535-1545)Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption(N Engl J Med 2019; 380:1535-1545)more -
Novel antibody may suppress HIV for up to four months(NIH News Releases)
Novel antibody may suppress HIV for up to four months(NIH News Releases)Novel antibody may suppress HIV for up to four months(NIH News Releases)more -
United BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicine
United BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of MedicineUnited BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicinemore -
美國時代雜誌對新英格蘭醫學期刊4月18日週刊發表之聯生藥UB-421突破性愛滋病臨床試驗結果相關報導
美國時代雜誌對新英格蘭醫學期刊4月18日週刊發表之聯生藥UB-421突破性愛滋病臨床試驗結果相關報導美國時代雜誌對新英格蘭醫學期刊4月18日週刊發表之聯生藥UB-421突破性愛滋病臨床試驗結果相關報導more -
聯生藥治療愛滋病抗體新藥UB-421臨床II期試驗結果 榮獲刊登於新英格蘭醫學期刊
聯生藥治療愛滋病抗體新藥UB-421臨床II期試驗結果 榮獲刊登於新英格蘭醫學期刊聯生藥治療愛滋病抗體新藥UB-421臨床II期試驗結果 榮獲刊登於新英格蘭醫學期刊more
